• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

75
61
58
57
8

COUNTRY

56
4
2
2
1

CATEGORIES

  • 147
  • 25
  • 15
  • 8
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

151
169
175
240

PUBLISHED

4
8
32
240

PRODUCT TYPE

138
78
15
6
2
1

Search "PharmaNet Development Group, Inc." returned 240 results.

PharmaNet Development Group Inc.

This PrivCo private company report on PharmaNet Development Group Inc. provides a detailed PharmaNet Development Group Inc. company profile, consisting of PharmaNet Development Group Inc. financials,...

August 2015

PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug, and medical device industries....

June 2014

PharmaNet Development Group, Inc. (Formerly SFBC International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM

PharmaNet Development Group Inc. - Company Capsule

Synopsis ICD Research's "PharmaNet Development Group Inc. - Company Capsule" contains a company overview, key facts, key employees, products and services, locations and subsidiaries as well as financial...

November 2011
FROM

PharmaNet Development Group Inc. Jul 10

Abstract PharmaNet is a solid mid-size player in the contract research industry and has an international presence; and The company has defensible niches in select therapeutic classes. PharmaNet is...

July 2010

Recovery Report: PharmaNet Development Group Inc.'s Recovery Rating Profile Apr 11

Abstract Standard and Poor's Rating Services is reviewing recovery ratings and issue level debt ratings on Princeton, N.J.-based drug development services company, PharmaNet Development Group Inc....

April 2011

Summary: PharmaNet Development Group Inc. Jan 11

Abstract The speculative grade ratings on Princeton, N.J.-based PharmaNet Development Group Inc. reflect the sponsor-owned company's aggressive financial risk profile and PharmaNet's need to continue...

January 2011

Summary: PharmaNet Development Group Inc. Jul 10

Abstract The speculative grade ratings on Princeton, N.J.-based PharmaNet Development Group Inc. reflect the sponsor-owned company's aggressive financial risk profile and PharmaNet's need to continue...

July 2010

PharmaNet Development Group Inc.'s Ratings Withdrawn Following Acquisition Jul 11

Abstract TORONTO (Standard & Poor's) July 27, 2011--Standard & Poor's Ratings Services said today that it withdrew its ratings on Princeton, N.J.-based contract pharmaceutical research organization...

July 2011

Research Update: PharmaNet Development Group Inc.'s Ratings Withdrawn Following Acquisition Jul 11

Abstract On July 27, 2011, Standard & Poor's Ratings Services withdrew its ratings on Princeton, N.J.-based contract pharmaceutical research organization PharmaNet Development Group Inc., following...

July 2011

Research Update: PharmaNet Development Group Inc. Corporate Credit Rated 'B+'; Outlook Is Stable Mar 10

Abstract After over one year of ownership, the financial sponsor, JLL Partners, is considering a debt-financed dividend from Princeton, N.J.-based PharmaNet Development Group Inc., one of larger players...

March 2010

PharmaNet Development Group Inc. Corporate Credit Rated 'B+'; Rating Outlook Is Stable Mar 10

Abstract After over one year of ownership, the financial sponsor, JLL Partners, is considering a debt-financed dividend from Princeton, N.J.-based PharmaNet Development Group Inc., one of larger players...

March 2010

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

June 2015
FROM

Catalent Pharma Solutions, Inc. - Strategy and SWOT Report

Catalent Pharma Solutions, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

April 2014
FROM

Gene Therapy Partnering Terms and Agreements (3rd Edition)

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2014
FROM

Nanotechnology - Global Strategic Business Report

This report analyzes the worldwide markets for Nanotechnology in US$ Billion by the following End-Use Sectors: Chemicals, Automotive, Aerospace & Defense, Semiconductors & Electronics, Pharma & Healthcare,...

September 2014
FROM

PharmaNet Development Group Inc Oct 06

Abstract Continued strong macro trends for the outsourced pharmaceutical research industry; Company's relatively strong cash flow generation; and Relatively low cost of debt. Company's short record...

October 2006

PharmaNet Development Group Inc Dec 07

Abstract Continued strong macro-level trends for the outsourced pharmaceutical research industry; Stabilization of operations after business difficulties of late-2005; and Relatively low cost of debt....

December 2007

Chronic Pain - Pipeline Review, H2 2013

Chronic Pain - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Chronic Pain - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

October 2013
FROM

Type 2 Diabetes - Pipeline Review, H1 2014

Type 2 Diabetes - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2014’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This...

February 2014
FROM
Loading Indicator

Our Clients

Symantec Corporation Sonoco Products Company Tiffany & Co. ITT Corporation Exxon Mobil Corp. Samsonite International S.A. Kellogg's Co.